Central Nervous System Multiple Sclerosis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Multiple Sclerosis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Multiple Sclerosis Projects
--Active Biotech
--Abbott Laboratories
--Bayer HealthCare Pharmaceuticals
--erly Berlex, Inc.)
--AutoImmune Inc
--BioMS Medical Corp.
--Biogen Idec Inc
--Centocor, Inc.
--BioPartners GmbH
--Eli Lilly & Co
--Elan Corp Plc
--Merck Serono S.A.
--Genentech Inc
--Novartis AG
--Millennium Pharmaceuticals Inc
--Pipex Pharmaceuticals, Inc.
--Pepgen Corporation
--Sanofi-Aventis
--Roche Holdings Ltd
--Teva Pharmaceutical Industries Ltd
--Teva Neuroscience

--Top Companies in early stage Multiple Sclerosis Projects
--Aegera Therapeutics Inc.
--Acorda Therapeutics Inc
--Biogen Idec Inc
--AstraZeneca Plc
--BTG plc
--Bionomics Limited
--Genentech Inc
--ChemoCentryx, Inc.
--Medivir AB
--Hollis-Eden Pharmaceuticals Inc
--Merrimack Pharmaceuticals, Inc.
--Merck Serono S.A.
--Peptimmune, Inc
--MultiCell Technologies Inc
--Plexxikon Inc
--Pharmaxis Ltd.
--Tolerx, Inc.
--Teva Pharmaceutical Industries Ltd
--ZymoGenetics Inc
--Xencor

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View